EUVIMEDEUVIMED entdecken
Multizentrische StudieRandomisierte kontrollierte StudieÄquivalenzstudie

Efficacy and Safety of 1‐L Polyethylene Glycol With Low Ascorbic Acid for Bowel Preparation: A Randomized Clinical Trial

Ji Eun Baek iD, Hyo Suk Kim iD, Sung Hoon Jung, Sang-Bum Kang iD, Bo-In Lee iD, Kang-Moon Lee iD

Journal of Gastroenterology and Hepatology · 2026-11 · 41 (11) · 3442-3450

DOI: 10.1111/jgh.70781 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of Gastroenterology and Hepatology, online erschienen am 30.09.2026. Verfasst von Ji Eun Baek und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Republic of Korea. Hauptthemen laut MEDLINE: Polyethylene Glycols, Ascorbic Acid, Colonoscopy, Cathartics. Die Arbeit nennt 29 Literaturangaben. Gefördert von: Taejoon Pharm.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and Aims Ultra‐low‐volume polyethylene glycol (PEG) with ascorbic acid (Asc) improves tolerability, but Asc‐related gastrointestinal and metabolic adverse events remain a concern. Whether reducing the Asc dose preserves cleansing efficacy without compromising safety is unclear. We compared a modified 1‐L PEG regimen with reduced Asc (1‐L PEG + low Asc) with standard 1‐L PEG + Asc and 2‐L PEG + Asc formulations.

Methods

In this multicenter, randomized, investigator‐blinded, three‐arm noninferiority trial across five hospitals, low‐risk adults undergoing colonoscopy were allocated (1:1:1) to 1‐L PEG + low Asc, 1‐L PEG + Asc, or 2‐L PEG + Asc. The primary endpoint was successful bowel cleansing by the Harefield Cleansing Scale (HCS). Secondary endpoints included Boston Bowel Preparation Scale (BBPS), endoscopic outcomes, gastric residual volume quantified by esophagogastroduodenoscopy, patient‐reported tolerability, and adverse events.

Results

Among 242 per‐protocol participants, HCS‐defined successful cleansing was achieved in 92.7% with 1‐L PEG + low Asc, 100.0% with 1‐L PEG + Asc, and 98.7% with 2‐L PEG + Asc ( p = 0.01). The low‐Asc regimen met noninferiority criteria versus both comparators (risk difference vs. 1‐L PEG + Asc, −7.3%; 97.5% CI, −13.0 to −1.6). BBPS‐defined success, adenoma detection rate (31.7%, 18.1%, and 20.8%), gastric fluid volume (27.4, 28.2, and 25.2 mL), and willingness to repeat the regimen (78.0%, 73.5%, and 71.4%) were similar across groups. Adverse‐event rates were comparable, with no electrolyte disturbances or renal events observed.

Conclusions

A modified 1‐L PEG regimen with reduced Asc provides bowel cleansing efficacy noninferior to both standard 1‐L and 2‐L PEG + Asc preparations, with comparable tolerability and safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polyethylene GlycolsAscorbic AcidColonoscopyCatharticsHumansFemaleMaleMiddle AgedTreatment OutcomeAgedAdult

Stichwörter der Autor:innen

ascorbic acidbowel preparationcolonoscopynoninferiority trialpolyethylene glycol

Substanzen

Polyethylene GlycolsAscorbic AcidCathartics

Autor:innen und Institutionen

  • Department of Internal Medicine, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Republic of Korea.
  • Department of Internal Medicine, Bucheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Bucheon, Republic of Korea.
  • Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
  • Department of Internal Medicine, Daejeon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Daejeon, Republic of Korea.
  • Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.

ORCID-Profile: Ji Eun Baek, Hyo Suk Kim, Sang-Bum Kang, Bo-In Lee, Kang-Moon Lee

Förderung

  • Taejoon Pharm

Zitieren

APA

Baek, J. E., Kim, H. S., Jung, S. H., Kang, S. B., Lee, B. I., & Lee, K. M. (2026). Efficacy and Safety of 1‐L Polyethylene Glycol With Low Ascorbic Acid for Bowel Preparation: A Randomized Clinical Trial. Journal of Gastroenterology and Hepatology, 41(11), 3442-3450. https://doi.org/10.1111/jgh.70781

Vancouver

Baek JE, Kim HS, Jung SH, Kang SB, Lee BI, Lee KM. Efficacy and Safety of 1‐L Polyethylene Glycol With Low Ascorbic Acid for Bowel Preparation: A Randomized Clinical Trial. Journal of Gastroenterology and Hepatology. 2026;41(11):3442-3450. doi:10.1111/jgh.70781

BibTeX
@article{Baek2026,
  author = {Baek, Ji Eun and Kim, Hyo Suk and Jung, Sung Hoon and Kang, Sang-Bum and Lee, Bo-In and Lee, Kang-Moon},
  title = {Efficacy and Safety of 1‐L Polyethylene Glycol With Low Ascorbic Acid for Bowel Preparation: A Randomized Clinical Trial},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2026},
  volume = {41},
  number = {11},
  pages = {3442--3450},
  doi = {10.1111/jgh.70781}
}
Kostenlos starten →